Guanfacine
These highlights do not include all the information needed to use GUANFACINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for GUANFACINE EXTENDED-RELEASE TABLETS. GUANFACINE extended-release tablets, for oral use Initial U.S. Approval: 1986
07a701e2-39b7-4bb1-a7c7-d9baed4ab18a
HUMAN PRESCRIPTION DRUG LABEL
Nov 7, 2023
TWi Pharmaceuticals, Inc.
DUNS: 658402052
Upsher-Smith Laboratories, LLC
DUNS: 047251004
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Guanfacine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (11)
Guanfacine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
Guanfacine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (11)
Guanfacine
Product Details
FDA regulatory identification and product classification information